TMEM39A

Across TCGA pan-cancer cohorts, TMEM39A Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated TMEM39A data layer compared with 23 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher TMEM39A Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated TMEM39A expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

ESCA, LIHC, and UCEC are the cancer types where TMEM39A Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	DFS	Median	II,III,IV	0.082	0.523	<.001	12	view →
LIHC	OS	Median	All	0.098	0.774	.001	12	view →
UCEC	DFS	Median	All	0.967	0.829	.030	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

TMEM39A–ESCA (DFS)

Open the ESCA breakdown →